Experts in every field
IP Checkups works with the world’s largest companies and greatest innovators to help manage their own patent portfolios, as well as those of their competitors.
Our team of in-house patent specialists each possess an extensive working knowledge of the industries we serve.
IP Checkups was founded in the San Francisco Bay Area in 2004 by Matthew and Irving Rappaport.
In the early 1990s, Irving Rappaport realized that the availability worldwide patent information in electronic format would revolutionize the field of intellectual property management.
This prompted Irving to start Aurigin systems with a mission to convert the world’s patent information from paper into electronic format, and to create a patent analytics workbench.
The massive electronic database included millions of patent documents and became one of the first “big data” experiments as new insights into corporate behavior could be derived from the data for the benefit of legal, marketing, R&D and business executives. The availability of this information created new ways to look at how companies handled IP assets in the context of corporate strategy. This paved the way for the field of Intellectual Asset Management.
IP Checkups established a proprietary process to extract maximum value from patent information, increase organizational knowledge and efficiency, and help strengthen companies’ return on their technology investment.
In 2007 IP Checkups developed PatentCAM software, an easy to use, centralized repository for R&D and legal teams to manage competitive patent information. The software furthers our mission to increase innovation efficiencies and reduce litigation risk.
Meet our team
He has managed hundreds of patent landscape analyses, market research, IP strategy, and valuation projects for large and small corporate clients, start-ups and investors.
Matthew serves as the industry liaison to the Fung Institute for Engineering Leadership at the University of California, Berkeley. Since 2010, Matthew has been selected as a member of the IAM Strategy 300, a list of the world’s leading IP strategists.
IRV RAPPAPORT, ESQ.
In 1992, Irving co-founded SmartPatents, which later became Aurigin Systems, a pioneer in the field legal software, for patent landscaping and analytics. In 2004, Irv and Matthew co-founded IP Checkups.
Irving serves as an expert witness in IP-related litigation, representing plaintiffs in the i4i v. Microsoft; Wi-LAN v. Acer et al, v. RIM et al, v. Westech et al; and Cornell University v. HP cases. Since 2009, Irving has been selected as a member of the IAM Strategy 300, a list of the world’s leading IP strategists.
Director of Operations
Mark’s deep understanding of patent information along with his mastery of software development and user interface technologies have enabled him to enhance the quality and comprehensiveness of IP Checkups’ software solutions.
Prior to joining IP Checkups in 2006, Mark spent five years as a professional audio and recording engineer for headlining acts throughout the country. He earned a B.S. in Computer Science from the University of Oklahoma.
STEVE KRAWCZYK, PHD
Director of Research & Strategy
Steve started at Gilead Sciences in 1989 as a medicinal chemist and in 2000 moved to Gilead’s IP department as a patent searcher and analyst. In 2006, he became the head of Patent Informatics, managing the patent search group and providing FTO, landscape searches, and design around assessments in support of M&A and partnering diligence.
Steve’s work at Gilead resulted in over 40 peer reviewed publications, patents and presentations. He earned his PhD in Medicinal Chemistry from the University of Michigan. Later he obtained an MBA through Golden Gate University and a JD from Santa Clara University.
MARK BOSSE, PHD
Intellectual Property Expert
Prior to joining Gilead, Mr. Bosse was an attorney at Syntex Corporation. In this role, Mr. Bosse’s practice focus was patent preparation and prosecution for the Syva Diagnostics business unit.
Mr. Bosse received his J.D. from Golden Gate University Law School, his Ph.D. in Organic Chemistry from University of California at Berkeley and his bachelor’s degree from Lewis and Clark College.
BRUCE RESNICK, PHD
Sr. Patent Analyst
He spent over 30 years working as a research manager (Kodak and International Paper) and an intellectual asset manager (Cargill). During that time Bruce and his team helped bring numerous concepts to commercialization. He and his colleagues won several awards for best product of the year.
Bruce has been a registered patent agent since 1994 and has prepared patent applications for a variety of companies and inventors. He did post-doctoral research at the University of Illinois-Champaign Urbana. Then,he earned a doctorate in chemistry from NYU. Bruce holds 17 patents in diverse areas including food science and silver halide photographic films.
JESSE HOOPER, EE
Dir. of Search & Analytics
Jesse started in the field of patent analytics in 2009 as a patent searcher and analyst. He is an expert on a variety of commercially available patent search and analytics tools.
Jesse has performed hundreds of freedom-to-operate, validity, and patentability searches.And, he has managed projects related to technology mapping and competitive analysis. Jesse’s technical experience spans a variety of areas including wireless, networking, internet-of-things, autonomous vehicles, 3D printing, biomedical devices, batteries, data storage, among others. Jesse earned a BS in Electrical Engineering from George Mason University in 2008.
KIRK HASELTON, PHD
Patent Strategy, IP Operations
After spending several years working in industrial R&D with Siemens Mobile and Nokia Siemens Networks, in 2008 Kirk began working exclusively with inventions, technology development and IP as a licensing manager with ipal, a subsidiary of the Investment Bank of Berlin. In 2013, Kirk started Haselton IP, based in Berlin, Germany.
Kirk holds a Bachelor of Science with Honors degree in Applied Physics from the California Institute of Technology and M.Sc. & Ph.D. degrees in Applied Physics from Cornell University. Kirk is a Hertz Fellow and the recipient of a NASA Fellowship, both in support of his Ph.D. research.
SAL FUERSTENBERG, PHD
Biologist, Patent Analyst
Sal earned her Ph.D. in Medical Sciences at the prestigious Karolinska Institute in Stockholm Sweden. From 1993-1996 Sal was a Postdoctoral Fellow at the Fred Hutchinson Cancer Research Center and from 1997-2004, Sal worked as a Postdoctoral Fellow at the Institute for Neuroscience at the University of Oregon.
Sal has research experience in the fields of virology, cancer biology, neuroscience, cellular developmental biology, microbiology, vaccines and diagnostics. She is fluent in Swedish and supports the Save the Children foundation, the Red Cross, the Southern Poverty Law Center, and the Yolo County Food Bank among others.
JENNIFER HAYNES, PHD
Biotech Patent Agent
Jennifer received her Ph.D. in Microbiology and Molecular Genetics from UCLA and worked for 5 years as a postdoctoral fellow at Childrens Hospital, Los Angeles studying the molecular biology of Ewing’s Sarcoma before changing careers to the patent field. During that time she also enjoyed teaching Microbiology classes for UCLA and Santa Monica College.
Jennifer has extensive patent experience writing and prosecuting biotechnology applications related to virology, vaccine work, enzymology, new PCR techniques, intra ocular lenses, the molecular biology of allergy, plant genetics, gene therapy, antimicrobial proteins, fermentation, immunology, and biofuel production among many others.
ROBERT KEAN, PHD
Physical Chemist, Patent Analyst, Ph.D.
Prior to joining IP Checkups, Robert held R&D and IP leadership positions at several companies including: Laboratory Director (Cortec Corporation), Biodegradable Technologies and Patents Manager (Cortec Corporation), Intellectual Asset Manager/Principal Chemist (NatureWorks LLC), and Intellectual Asset Manager (Cargill).
Robert has been a registered patent agent since 2001. He has a Ph.D. in Physical Chemistry from Michigan State University and conducted post-doctoral research at the University of Minnesota Department of Biochemistry.
Phil earned a B.A. with honors in chemistry from Boston University and worked as a medicinal chemist at Amgen Biotechnology for 7 years. His work contributed to seven publications and three US patents including VEGF/KDR targets towards angiogenic-related cancer and delivery of a p53-focused clinical trial candidate.
Phil is currently completing his PhD in Civil Engineering with a focus on material science and bioengineering. His exploration of the physiochemical interactions between designed surfaces and bacterial cells have informed biofilm engineering towards bio-remediation and antimicrobial surfaces for use in medical environments.
What our clients say
Director of Patent Liaisons, Fortune 500 Packaging Firm
Below is a select list of exemplary clients:
PatentCAM supports Big Pharma Co’s successful launch of multi-billion dollar drug.
In an effort to develop best-in-class new chemical entities, one of the world’s largest biopharma companies licensed the PatentCAM™ software for the R&D team to track and monitor competitive patent information in real time.
With patent expirations related to its franchise products on the horizon, the company needed to produce a new blockbuster drug in order to keep its share price from dropping.
Managing thousands of patents related to diverse targets and mechanisms of action while monitoring newly published patents using traditional patent search tools or Microsoft Excel was not a realistic solution.
The company licensed PatentCAM, a reliable software solution for managing, reviewing, and monitoring competitive patent information across a variety of categories.
First, IP Checkups identified, reviewed and summarized pertinent information for thousands of historical patents into relevant technology categories.
Next, IP Checkups delivered the information in PatentCAM for the entire R&D team. This provided a centralized repository to perform ongoing review, sorting, summarizing and commenting on relevant patents.
Finally, PatentCAM was updated twice per week as new patents published in worldwide authorities enabling the R&D team to stay on top of the most current competitor innovations.
IPC’s customer released its first approved product related to the project 5 years after deployment of PatentCAM. Several more product releases are making their way through clinical trials now.
$20 billion estimated product revenues over the next several years
The R&D team has expanded three-fold and the share price of the company has increased exponentially over the past eight years.